Form 4: aTyr Pharma CFO Jill Marie Broadfoot Increases Stake in Company

Jill Marie Broadfoot, CFO of aTyr Pharma, recently purchased 5,000 shares of the company's common stock at a price of $1.79 per share.

Summary

• On May 31, 2024, Jill Marie Broadfoot, the Chief Financial Officer of aTyr Pharma Inc., purchased 5,000 shares of the company's common stock.
• The purchase price was $1.79 per share.
• Following the transaction, Ms. Broadfoot directly owns 27,960 shares of aTyr Pharma.
• Ms. Broadfoot also acquired 2,139 shares on May 15, 2024, under the company's 2015 Employee Purchase Plan.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as the CFO's stock purchase suggests confidence in the company's prospects. However, it's a single transaction and doesn't provide a comprehensive view of the company's overall health.

Positives

• The CFO's purchase of company stock may signal confidence in the company's future prospects.

Industry Context

Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's valuation and future performance. Purchases are generally seen as a positive sign.

Stakeholder Impact

• The CFO's stock purchase could positively influence shareholder sentiment.

Key Dates